Final Results from A Phase 2 Study of Squalamine Lactate Ophthalmic Solution 0.2% (Ohr-102) in the Treatment of Neovascular Age-Related Macular Degeneration (Amd)
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2015）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined